181 related articles for article (PubMed ID: 25177920)
1. Berberine-loaded targeted nanoparticles as specific Helicobacter pylori eradication therapy: in vitro and in vivo study.
Lin YH; Lin JH; Chou SC; Chang SJ; Chung CC; Chen YS; Chang CH
Nanomedicine (Lond); 2015 Jan; 10(1):57-71. PubMed ID: 25177920
[TBL] [Abstract][Full Text] [Related]
2. Genipin-cross-linked fucose-chitosan/heparin nanoparticles for the eradication of Helicobacter pylori.
Lin YH; Tsai SC; Lai CH; Lee CH; He ZS; Tseng GC
Biomaterials; 2013 Jun; 34(18):4466-79. PubMed ID: 23499480
[TBL] [Abstract][Full Text] [Related]
3. Development of novel nanoparticles shelled with heparin for berberine delivery to treat Helicobacter pylori.
Chang CH; Huang WY; Lai CH; Hsu YM; Yao YH; Chen TY; Wu JY; Peng SF; Lin YH
Acta Biomater; 2011 Feb; 7(2):593-603. PubMed ID: 20813208
[TBL] [Abstract][Full Text] [Related]
4. Amoxicillin, clarithromycin, and omeprazole based targeted nanoparticles for the treatment of H. pylori.
Ramteke S; Ganesh N; Bhattacharya S; Jain NK
J Drug Target; 2009 Apr; 17(3):225-34. PubMed ID: 19241256
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticles incorporated in pH-sensitive hydrogels as amoxicillin delivery for eradication of Helicobacter pylori.
Chang CH; Lin YH; Yeh CL; Chen YC; Chiou SF; Hsu YM; Chen YS; Wang CC
Biomacromolecules; 2010 Jan; 11(1):133-42. PubMed ID: 19924885
[TBL] [Abstract][Full Text] [Related]
6. Design and evaluation of novel pH-sensitive ureido-conjugated chitosan/TPP nanoparticles targeted to Helicobacter pylori.
Jing ZW; Jia YY; Wan N; Luo M; Huan ML; Kang TB; Zhou SY; Zhang BL
Biomaterials; 2016 Apr; 84():276-285. PubMed ID: 26851392
[TBL] [Abstract][Full Text] [Related]
7. The potential utility of chitosan micro/nanoparticles in the treatment of gastric infection.
Gonçalves IC; Henriques PC; Seabra CL; Martins MC
Expert Rev Anti Infect Ther; 2014 Aug; 12(8):981-92. PubMed ID: 24981812
[TBL] [Abstract][Full Text] [Related]
8. Construction and optimization of pH-sensitive nanoparticle delivery system containing PLGA and UCCs-2 for targeted treatment of Helicobacter pylori.
Luo M; Jia YY; Jing ZW; Li C; Zhou SY; Mei QB; Zhang BL
Colloids Surf B Biointerfaces; 2018 Apr; 164():11-19. PubMed ID: 29367052
[TBL] [Abstract][Full Text] [Related]
9. Anti-Helicobacterpylori effectiveness and targeted delivery performance of amoxicillin-UCCs-2/TPP nanoparticles based on ureido-modified chitosan derivative.
Jing ZW; Luo M; Jia YY; Li C; Zhou SY; Mei QB; Zhang BL
Int J Biol Macromol; 2018 Aug; 115():367-374. PubMed ID: 29660462
[TBL] [Abstract][Full Text] [Related]
10. Development of pH-responsive chitosan/heparin nanoparticles for stomach-specific anti-Helicobacter pylori therapy.
Lin YH; Chang CH; Wu YS; Hsu YM; Chiou SF; Chen YJ
Biomaterials; 2009 Jul; 30(19):3332-42. PubMed ID: 19299008
[TBL] [Abstract][Full Text] [Related]
11. Lectin-Conjugated Clarithromycin and Acetohydroxamic Acid-Loaded PLGA Nanoparticles: a Novel Approach for Effective Treatment of H. pylori.
Jain SK; Haider T; Kumar A; Jain A
AAPS PharmSciTech; 2016 Oct; 17(5):1131-40. PubMed ID: 26566630
[TBL] [Abstract][Full Text] [Related]
12. Preparation of epigallocatechin gallate-loaded nanoparticles and characterization of their inhibitory effects on
Lin YH; Feng CL; Lai CH; Lin JH; Chen HY
Sci Technol Adv Mater; 2014 Aug; 15(4):045006. PubMed ID: 27877707
[TBL] [Abstract][Full Text] [Related]
13. Preparation, in vitro and in vivo evaluation of stomach-specific metronidazole-loaded alginate beads as local anti-Helicobacter pylori therapy.
Ishak RA; Awad GA; Mortada ND; Nour SA
J Control Release; 2007 Jun; 119(2):207-14. PubMed ID: 17412443
[TBL] [Abstract][Full Text] [Related]
14. Anti-Helicobacter pylori effect of mucoadhesive nanoparticles bearing amoxicillin in experimental gerbils model.
Umamaheshwari RB; Ramteke S; Jain NK
AAPS PharmSciTech; 2004 Apr; 5(2):e32. PubMed ID: 15760090
[TBL] [Abstract][Full Text] [Related]
15. Combating Helicobacter pylori infections with mucoadhesive nanoparticles loaded with Garcinia mangostana extract.
Pan-in P; Tachapruetinun A; Chaichanawongsaroj N; Banlunara W; Suksamrarn S; Wanichwecharungruang S
Nanomedicine (Lond); 2014 Mar; 9(3):457-68. PubMed ID: 23731457
[TBL] [Abstract][Full Text] [Related]
16. Engineering resveratrol-loaded chitosan nanoparticles for potential use against Helicobacter pylori infection.
Spósito L; Fonseca D; Gonçalves Carvalho S; Sábio RM; Marena GD; Bauab TM; Bagliotti Meneguin A; Parreira P; L Martins MC; Chorilli M
Eur J Pharm Biopharm; 2024 Jun; 199():114280. PubMed ID: 38588828
[TBL] [Abstract][Full Text] [Related]
17. Development and characterization of nanolipobeads-based dual drug delivery system for H. pylori targeting.
Jain AK; Jain SK
J Drug Target; 2013 Jul; 21(6):593-603. PubMed ID: 23597027
[TBL] [Abstract][Full Text] [Related]
18. Development of novel pH-sensitive thiolated chitosan/PMLA nanoparticles for amoxicillin delivery to treat Helicobacter pylori.
Arif M; Dong QJ; Raja MA; Zeenat S; Chi Z; Liu CG
Mater Sci Eng C Mater Biol Appl; 2018 Feb; 83():17-24. PubMed ID: 29208276
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro studies of cross-linked hydrogel nanoparticles containing amoxicillin.
Moogooee M; Ramezanzadeh H; Jasoori S; Omidi Y; Davaran S
J Pharm Sci; 2011 Mar; 100(3):1057-66. PubMed ID: 21280053
[TBL] [Abstract][Full Text] [Related]
20. Polyelectrolyte coated multilayered liposomes (nanocapsules) for the treatment of Helicobacter pylori infection.
Jain P; Jain S; Prasad KN; Jain SK; Vyas SP
Mol Pharm; 2009; 6(2):593-603. PubMed ID: 19718807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
